The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Fujifilm Corporation has agreed to invest JYP 100 million ($918 million) into Cuorips, a Tokyo-based start-up company developing regenerative medicines for treating heart failure, through underwriting a third-party allocation of shares. It also...
The latest from CDMOs, CMOs, and suppliers featuring Arranta Bio, AGC Biologics, Vetter, Metrics Contract Services, CapsCanada, LabVantage, Univercells, and others.
Biologics Manufacturing
Arranta Bio To Add New $150 M-Mfg Facility for Live...
Thermo Fisher Scientific has announced more than $600 million in capital investments to expand its bioprocessing materials capacity through 2022 to more than double the company's current manufacturing capacity.
Specific investments include...
The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Diosynth, WuXi AppTec, Cytiva, Grand River Aseptic Manufacturing (GRAM), Stevanato Group, and others.
Chemicals/Chemical API Manufacturing
Phlow, USP Form Continuous Mfg Pact for...
W.R. Grace, a specialty chemical company, has agreed to acquire the fine chemistry services business of Albemarle for approximately $570 million ($300 million upfront in cash and $270 million in equity).
The acquisition adds analytical, regulatory...
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Almac, Avid Bioservices, Stevanato Group, Eurofins, and Intravacc.
Chemicals/Chemical API Manufacturing
Almac Completes $7-M Investment for Center for Chemical R&DAlmac Sciences,...
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Lonza, Thermo Fisher, Fujifilm, Regis, Cascade Chemistry, Wavelength Pharmaceuticals, and others.
Chemicals/Chemical API Manufacturing
Regis Expands Facilities for API Development,...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Evonik, Fujifilm Diosynth Biotechnologies, and Kaneka.
Biologics Manufacturing
Fujifilm To Produce Antigen for Novavax’s COVID-19 Vaccine Fujifilm Diosynth Biotechnologies, a...
Charles River Laboratories, a Wilmington, Massachusetts-headquartered contract research organization, has agreed to acquire Cognate BioServices, a CDMO specializing in cell and cell-mediated gene-therapy products, for approximately $875...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Avid Bioservices and Abzena.
Biologics Manufacturing
Avid Bioservices, Humanigen in Mfg Pact for COVID-19 TherapeuticAvid Bioservices, a biologics CDMO, and Humanigen, a...
The latest from CDMOs, CMOs, and suppliers featuring Quotient Sciences, Recipharm, Catalent, RentschlerBiopharma, Vigene, TCG Lifesciences, and Argonaut Manufacturing Services.
Chemicals/Chemical API Manufacturing
TCG GreenChem Launches as a New...
Lonza has agreed to sell its Specialty Ingredients business and operations to Bain Capital and Cinven, two private-equity firms, for an enterprise value of CHF 4.2 billion ($4.7 billion).
Lonza’s Specialty Ingredients business provides microbial...
The latest from CDMOs, CMOs, and suppliers featuring Cytiva, Sai Life Sciences, Recipharm, and Medspray.
Chemicals/Chemical API Manufacturing
Sai Life Sciences To Expand API Development, Mfg in the UKSai Life Sciences, a Hyderabad,...
WuXi STA, a subsidiary of WuXi AppTec, has agreed to purchase Bristol-Myers Squibb’s manufacturing facility in Couvet, Switzerland. The facility has commercial-scale production capacity for capsule and tablet dosage forms.
The companies anticipate...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Emergent BioSolutions, Ajinomoto Bio-Pharma Services, and Just–Evotec.
Biologics Manufacturing
Just–Evotec Expands US Gov’t Contract for Mfg of mAbs for COVID-19 Just–Evotec...
